|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A01N 43/62 | |
| A61K 31/55 | |||
| C07D 413/04 | |||
| C07D 413/14 | |||
| C07D 249/06 |
| (11) | Patento numeris | 2680697 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12776679.8 |
| Europos patento paraiškos padavimo data | 2012-02-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-01-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-01-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/026691 |
| Data | 2012-02-27 |
| (87) | Numeris | WO 2012/148553 |
| Data | 2012-11-01 |
| (30) | Numeris | Data | Šalis |
| 201161448814 P | 2011-03-03 | US |
| (72) |
BAXTER, Carl, A., GB
CLEARTOR, Edward, GB
KRSKA, Shane, W., US
SHEEN, Faye, GB
STEWART, Gavin, GB
STROTMAN, Neil, US
WALLACE, Debra, J., US
WRIGHT, Timothy, US
|
| (73) |
Merck Sharp & Dohme Limited,
Hertford Road, Hoddesdon, Hertfordshire EN11 9BU,
GB
Merck Sharp & Dohme Corp., 126 East Lincoln Avenue, Rahway, NJ 07065-0907, US |
| (54) | PROCESS FOR THE PREPARATION OF AN OREXIN RECEPTOR ANTAGONIST |
| PROCESS FOR THE PREPARATION OF AN OREXIN RECEPTOR ANTAGONIST |